Antibiotic Therapy

Brand Name Molecule ATC Category Packaging Class
Chimono Lomefloxacine Systemic antibacterials 5 tablets 400 mg A
Overal Roxithromycin Systemic antibacterials 12 tablets 150 mg A
12 delitescent tablets 50 mg A
6 tablets 300 mg A
Supracef Cefixime Systemic antibacterials 5 dispersible tablets 400 mg A
100 mg / 5 ml for oral suspension A

Our products

Lusofarmaco can claim extensive know-how in various therapeutic areas: cardiovascular and respiratory diseases, antibiotic therapy, neuropsychiatry and gynecology.

Research & Development

For many years, Lusofarmaco has been mainly a national company, with a portfolio focused on well-established medicinal products, which have been the reference drugs in their respective therapeutic areas.

Pharmacovigilance

Pharmacovigilance: what does it mean to monitor drugs?

Registered Office:
Milanofiori – Strada 6, Edificio L – 20089 Rozzano (MI)
Tel. 02-516555.1 - Fax 02-516555.249

Registration No. In Registrar Of Companies: 00714810157
Registrar Of Companies' Office: Milano
Registered Capital: € 130.000 I.V.
Capital Reported In Last Financial Statement: € 130.000
Company subject to the direction and coordination of A. Menarini Industrie Farmaceutiche Riunite Srl

SITEMAP

Copyright 2021 Istituto Lusofarmaco D'Italia S.p.A.